School of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, TX, USA.
Department of Biological Sciences, The University of Texas at Dallas, Richardson, TX, USA.
Pain. 2018 Jul;159(7):1325-1345. doi: 10.1097/j.pain.0000000000001217.
Molecular neurobiological insight into human nervous tissues is needed to generate next-generation therapeutics for neurological disorders such as chronic pain. We obtained human dorsal root ganglia (hDRG) samples from organ donors and performed RNA-sequencing (RNA-seq) to study the hDRG transcriptional landscape, systematically comparing it with publicly available data from a variety of human and orthologous mouse tissues, including mouse DRG (mDRG). We characterized the hDRG transcriptional profile in terms of tissue-restricted gene coexpression patterns and putative transcriptional regulators, and formulated an information-theoretic framework to quantify DRG enrichment. Relevant gene families and pathways were also analyzed, including transcription factors, G-protein-coupled receptors, and ion channels. Our analyses reveal an hDRG-enriched protein-coding gene set (∼140), some of which have not been described in the context of DRG or pain signaling. Most of these show conserved enrichment in mDRG and were mined for known drug-gene product interactions. Conserved enrichment of the vast majority of transcription factors suggests that the mDRG is a faithful model system for studying hDRG, because of evolutionarily conserved regulatory programs. Comparison of hDRG and tibial nerve transcriptomes suggests trafficking of neuronal mRNA to axons in adult hDRG, and are consistent with studies of axonal transport in rodent sensory neurons. We present our work as an online, searchable repository (https://www.utdallas.edu/bbs/painneurosciencelab/sensoryomics/drgtxome), creating a valuable resource for the community. Our analyses provide insight into DRG biology for guiding development of novel therapeutics and a blueprint for cross-species transcriptomic analyses.
需要深入了解人类神经系统的分子神经生物学,以开发治疗慢性疼痛等神经疾病的下一代疗法。我们从器官捐献者获得人背根神经节 (hDRG) 样本,并进行 RNA 测序 (RNA-seq) 以研究 hDRG 的转录图谱,系统地将其与来自各种人类和同源小鼠组织(包括小鼠 DRG (mDRG) 的公开可用数据进行比较。我们根据组织受限基因共表达模式和潜在转录调节剂来描述 hDRG 的转录谱,并制定了一种信息论框架来量化 DRG 富集。还分析了相关的基因家族和途径,包括转录因子、G 蛋白偶联受体和离子通道。我们的分析揭示了一个 hDRG 丰富的蛋白编码基因集(约 140 个),其中一些在 DRG 或疼痛信号中尚未描述。其中大多数在 mDRG 中表现出保守的富集,并挖掘了已知的药物-基因产物相互作用。绝大多数转录因子的保守富集表明,由于进化上保守的调控程序,mDRG 是研究 hDRG 的忠实模型系统。hDRG 和胫骨神经转录组的比较表明神经元 mRNA 向成人 hDRG 轴突的运输,与啮齿动物感觉神经元轴突运输的研究一致。我们将我们的工作作为一个在线、可搜索的存储库(https://www.utdallas.edu/bbs/painneurosciencelab/sensoryomics/drgtxome)呈现,为社区创建了一个有价值的资源。我们的分析为指导新型治疗药物的开发提供了 DRG 生物学的深入了解,并为跨物种转录组分析提供了蓝图。